1-3 of 3
Joost H. A. Martens
Close
Sort by
Journal Articles

Large-scale in vitro production of red blood cells from human peripheral blood mononuclear cells

Steven Heshusius, Esther Heideveld, Patrick Burger, Marijke Thiel-Valkhof, Erica Sellink, Eszter Varga, Elina Ovchynnikova, Anna Visser, Joost H. A. Martens, Marieke von Lindern, Emile van den Akker
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3337–3350.
https://doi.org/10.1182/bloodadvances.2019000689
Published: 2019
Includes: Supplemental data
Journal Articles

Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern

Gerbrig Berger, Mylene Gerritsen, Guoqiang Yi, Theresia N. Koorenhof-Scheele, Leonie I. Kroeze, Marian Stevens-Kroef, Kenichi Yoshida, Yuichi Shiraishi, Eva van den Berg, Hein Schepers, Geert Huls, André B. Mulder, Seishi Ogawa, Joost H. A. Martens, Joop H. Jansen, Edo Vellenga
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3111–3122.
https://doi.org/10.1182/bloodadvances.2019000518
Published: 2019
Includes: Supplemental data
Journal Articles

RUNX1 mutations enhance self-renewal and block granulocytic differentiation in human in vitro models and primary AMLs

Mylène Gerritsen, Guoqiang Yi, Esther Tijchon, Jorren Kuster, Jan Jacob Schuringa, Joost H. A. Martens, Edo Vellenga
Journal: Blood Advances
Blood Adv (2019) 3 (3): 320–332.
https://doi.org/10.1182/bloodadvances.2018024422
Published: 2019
Includes: Supplemental data